Vasoactive Peptides in Portal Pressure

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Bayside Health.
Recruitment status was  Recruiting
Information provided by:
Bayside Health Identifier:
First received: September 13, 2005
Last updated: July 25, 2007
Last verified: September 2005
This study is looking at the detection of vasoactive peptides in portal hypertension.

Condition Intervention
Portal Hypertension
Drug: Norfloxacin

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Bayside Health:


Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both

Inclusion Criteria:

  • HVPG >= 12 mmHg
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00163982

Contact: William W Kemp, MBBS, FRACP 92762000 ext 3327

Australia, Victoria
Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3181
Contact: William W Kemp, MBBS, FRACP    92762000 ext 3327   
Sponsors and Collaborators
Bayside Health
Principal Investigator: William W Kemp, MBBS, FRACP The Alfred
  More Information Identifier: NCT00163982     History of Changes
Other Study ID Numbers: AH4204 
Study First Received: September 13, 2005
Last Updated: July 25, 2007
Health Authority: Australia: Human Research Ethics Committee

Keywords provided by Bayside Health:
HVPG > 12 mmHg

Additional relevant MeSH terms:
Hypertension, Portal
Digestive System Diseases
Liver Diseases processed this record on May 26, 2016